Clinical trial
INcreased Flow Utilizing Subcutaneously-Enabled Pediatric Rehydration (INFUSE-Pediatric Rehydration Study): Phase IV Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase (HYLENEX) for Infants and Children
NCT00477152 is registered in ClinicalTrials.gov with Baxter Healthcare Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INcreased Flow Utilizing Subcutaneously-Enabled Pediatric Rehydration (INFUSE-Pediatric Rehydration Study): Phase IV Study of Subcutaneous Rehydration With Recombinant Human Hyaluronidase (HYLENEX) for Infants and Children
- Lead sponsor
- Baxter Healthcare Corporation
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 52 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.